中文 | English
Return
Total: 399 , 1/40
Show Home Prev Next End page: GO
Author:(Jun-Jie CHENG)

1. A network pharmacology-based approach to explore mechanism of kaempferol-7 -O -neohesperidoside against prostate cancer

Qiu-Ping ZHANG ; Zhi-Ping CHENG ; Wei XUE ; Qiao-Feng LI ; Hong-Wei GUO ; Qiu-Ping ZHANG ; Jie-Jun FU ; Hong-Wei GUO

Chinese Pharmacological Bulletin 2024;40(1):146-154

2.Lanthanide Metal Organic Framework as A New Unlabeled Fluorescence Anisotropy Probe for Detection of Phosphate Ions

Kai MAO ; Xiao-Yan WANG ; Yu-Jie LUO ; Jia-Li XIE ; Tian-Jin XIE ; Yuan-Fang LI ; Cheng-Zhi HUANG ; Shu-Jun ZHEN

Chinese Journal of Analytical Chemistry 2024;52(1):35-44,中插1-中插4

3.Comparison of the predictive value of new simplified insulin resistance assessment indexes in identifying left ventricular subclinical dysfunction in T2DM patients

Yan-Yan CHEN ; Meng-Ying LI ; Jie ZHOU ; Jian-Fang FU ; Ying ZHANG ; Yi WANG ; Cheng WANG ; Xiang-Yang LIU ; Sheng-Jun TA ; Li-Wen LIU ; Ze-Ping LI ; Xiao-Miao LI

Medical Journal of Chinese People's Liberation Army 2024;49(2):137-143

4.Clinical trial of Morinda officinalis oligosaccharides in the continuation treatment of adults with mild and moderate depression

Shu-Zhe ZHOU ; Zu-Cheng HAN ; Xiu-Zhen WANG ; Yan-Qing CHEN ; Ya-Ling HU ; Xue-Qin YU ; Bin-Hong WANG ; Guo-Zhen FAN ; Hong SANG ; Ying HAI ; Zhi-Jie JIA ; Zhan-Min WANG ; Yan WEI ; Jian-Guo ZHU ; Xue-Qin SONG ; Zhi-Dong LIU ; Li KUANG ; Hong-Ming WANG ; Feng TIAN ; Yu-Xin LI ; Ling ZHANG ; Hai LIN ; Bin WU ; Chao-Ying WANG ; Chang LIU ; Jia-Fan SUN ; Shao-Xiao YAN ; Jun LIU ; Shou-Fu XIE ; Mao-Sheng FANG ; Wei-Feng MI ; Hong-Yan ZHANG

The Chinese Journal of Clinical Pharmacology 2024;40(6):815-819

5.Clinical trial of empagliflozin and linagliptin in the treatment of patients with type 2 diabetes mellitus with heart failure

Guang-Hui CHENG ; Xin-Jun LI ; Ying-Jie LI ; Hui WANG ; Dan-Dan CUI ; Hai-Yang ZHANG ; Zi-Jian WANG

The Chinese Journal of Clinical Pharmacology 2024;40(8):1131-1135

6.Research progress on drug resistance mechanism of sorafenib in radioiodine refractory differentiated thyroid cancer

En-Tao ZHANG ; Hao-Nan ZHU ; Zheng-Ze WEN ; Cen-Hui ZHANG ; Yi-Huan ZHAO ; Ying-Jie MAO ; Jun-Pu WU ; Yu-Cheng JIN ; Xin JIN

The Chinese Journal of Clinical Pharmacology 2024;40(13):1986-1990

7.One case of coronary intervention treatment for acute occlusion of the left circumflex artery with rare abnormal origin

Tao LI ; Zhen-Ye CHENG ; Xue-Xiang LI ; Jun-Jie ZHANG ; Xin WANG ; Wei ZHANG

Chinese Journal of Interventional Cardiology 2024;32(2):112-115

8.Research progress on the pathogenesis and treatment of gallbladder cancer

Jian-Qiang CAO ; Sheng-Biao YANG ; Xi-Qiang WANG ; Hui-Jie GAO ; Zhao-Bin HE ; Cheng PENG ; Jun NIU

Chinese Journal of Current Advances in General Surgery 2024;27(2):85-91

9.Drug prophylaxis evidence-based regimens for venous thromboembolism after joint replacement

Xiaowei FENG ; Na GUO ; Baozhen WANG ; Jie CHENG ; Yuchen TANG ; Jun QI ; Zhiqiang DONG

China Pharmacy 2024;35(22):2799-2807

10.Design of embedded cervical spine health intelligent system

Qian-Cheng ZHANG ; Wan-Yue ZHOU ; Jie-Min HUANG ; Jun-Ying GONG ; Yong-Ling HE

Chinese Medical Equipment Journal 2024;45(8):26-31

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 399 , 1/40 Show Home Prev Next End page: GO